Povidone

CHEMBL2108139 Phase 4 Đã phê duyệt Unknown
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Povidone (polyvinylpyrrolidone, PVP) is a water-soluble synthetic polymer used primarily as a pharmaceutical excipient functioning as a binder, disintegrant, and solubilizing agent in tablet and capsule formulations. Medically, povidone solutions have been used as plasma volume expanders during World War II and are also used as a carrier matrix for iodine in povidone-iodine antiseptic formulations.

Lĩnh vực điều trị

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

Povidone (polyvinylpyrrolidone, PVP) is a water-soluble synthetic polymer used primarily as a pharmaceutical excipient functioning as a binder, disintegrant, and solubilizing agent in tablet and capsule formulations. Medically, povidone solutions have been used as plasma volume expanders during World War II and are also used as a carrier matrix for iodine in povidone-iodine antiseptic formulations.

Yes, Povidone is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2108139. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.